Stock Events

Stock Events

Sartorius Stedim Biotech. 

$190
119
+$9+4.97% Tuesday 18:37

Statistics

Day High
190
Day Low
190
52W High
259.5
52W Low
178.3
Volume
100
Avg. Volume
-
Mkt Cap
18.49B
P/E Ratio
55.86
Dividend Yield
0.42%
Dividend
0.8

Upcoming

1
APR 27
Dividend Ex
Estimated
 
2
APR 27
Dividend Payment
Estimated
 
3
APR 28
Dividend Ex
Estimated
 
4
APR 28
Dividend Payment
Estimated
 

Dividends

0.42%Dividend Yield
Apr 26
$0.8
Apr 25
$0.76
Apr 24
$0.74
Apr 23
$1.57
Apr 22
$1.4
10Y Growth
7.85%
5Y Growth
-0.02%
3Y Growth
-20.14%
1Y Growth
4.92%

Earnings

23JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.98
1.16
1.34
1.52
Expected EPS
1.5167987512
Actual EPS
N/A

Financials

8.93%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.9BRevenue
615.91MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDMHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific offers a broad range of bioprocessing products and services, directly competing with Sartorius Stedim Biotech's offerings in the biotechnology and pharmaceutical manufacturing sectors.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation, through its Life Sciences segment, provides a variety of bioprocessing technologies, tools, and services that compete with Sartorius Stedim Biotech's product portfolio.
GE HealthCare Technologies
GEHC
Mkt Cap27.76B
GE Healthcare, a subsidiary of General Electric, offers bioprocessing equipment and technologies that rival those of Sartorius Stedim Biotech, especially in the areas of cell culture, filtration, and purification.
Bio-Rad Laboratories
BIO
Mkt Cap6.93B
Bio-Rad Laboratories provides products and services in the field of life science research and clinical diagnostics, competing with Sartorius Stedim Biotech in the bioprocessing and laboratory equipment market.
Avantor
AVTR
Mkt Cap5.43B
Avantor provides products and services for the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, competing with Sartorius Stedim Biotech in bioprocessing solutions.
Repligen
RGEN
Mkt Cap6.67B
Repligen Corporation offers bioprocessing technologies and systems that serve the same market as Sartorius Stedim Biotech, making them direct competitors in the biotechnology product manufacturing space.
Illumina
ILMN
Mkt Cap20.63B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, competing with Sartorius Stedim Biotech in the broader biotech market, particularly in the areas of research and development.
Waters
WAT
Mkt Cap30.15B
Waters Corporation produces analytical standards and reagents, chromatography columns, and laboratory analytical instruments that compete with Sartorius Stedim Biotech's laboratory products.
Agilent Technologies
A
Mkt Cap32.36B
Agilent Technologies offers life sciences, diagnostics, and applied chemical markets with instruments, services, consumables, applications, and expertise, competing with Sartorius Stedim Biotech in providing comprehensive solutions for the biotech industry.

About

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Show more...
CEO
Dr. Rene Faber
Employees
9961
Country
France
ISIN
FR0013154002

Listings

MX
MX
DIMN.MX
STU
DE
56S0.STU
STU
DE
56S1.STU
PA
FR
DIM.PA

0 Comments

Share your thoughts

FAQ

What is Sartorius Stedim Biotech. stock price today?▼
The current price of SDMHF is $190 USD — it has increased by +4.97% in the past 24 hours. Watch Sartorius Stedim Biotech. stock price performance more closely on the chart.
What is Sartorius Stedim Biotech. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sartorius Stedim Biotech. stocks are traded under the ticker SDMHF.
Is Sartorius Stedim Biotech. stock price growing?▼
SDMHF stock has risen by +5.47% compared to the previous week, the month change is a -6.75% fall, over the last year Sartorius Stedim Biotech. has showed a -21.42% decrease.
What is Sartorius Stedim Biotech. market cap?▼
Today Sartorius Stedim Biotech. has the market capitalization of 18.49B
When is the next Sartorius Stedim Biotech. earnings date?▼
Sartorius Stedim Biotech. is going to release the next earnings report on July 23, 2026.
What were Sartorius Stedim Biotech. earnings last quarter?▼
SDMHF earnings for the last quarter are 1.35 USD per share, whereas the estimation was 1.4 USD resulting in a -3.4% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sartorius Stedim Biotech. revenue for the last year?▼
Sartorius Stedim Biotech. revenue for the last year amounts to 6.9B USD.
What is Sartorius Stedim Biotech. net income for the last year?▼
SDMHF net income for the last year is 615.91M USD.
Does Sartorius Stedim Biotech. pay dividends?▼
Yes, SDMHF dividends are paid annual. The last dividend per share was 0.8 USD. As of today, Dividend Yield (FWD)% is 0.42%.
How many employees does Sartorius Stedim Biotech. have?▼
As of May 06, 2026, the company has 9,961 employees.
In which sector is Sartorius Stedim Biotech. located?▼
Sartorius Stedim Biotech. operates in the Health & Wellness sector.
When did Sartorius Stedim Biotech. complete a stock split?▼
The last stock split for Sartorius Stedim Biotech. was on June 02, 2016 with a ratio of 6:1.
Where is Sartorius Stedim Biotech. headquartered?▼
Sartorius Stedim Biotech. is headquartered in Aubagne, France.